Effects of exogenous melatonin supplementation on health outcomes: An umbrella review of meta-analyses based on randomized controlled trials.

Lim, Soojin; Park, Seoyeon; Koyanagi, Ai; Yang, Jae Won; Jacob, Louis; Yon, Dong Keon; Lee, Seung Won; Kim, Min Seo; Il Shin, Jae; Smith, Lee

Lim, Soojin; Park, Seoyeon; Koyanagi, Ai; Yang, Jae Won; Jacob, Louis; Yon, Dong Keon; Lee, Seung Won; Kim, Min Seo; Il Shin, Jae; Smith, Lee.

Affiliation

Lim S; Yonsei University College of Medicine, Seoul, Republic of Korea.
Park S; Yonsei University College of Medicine, Seoul, Republic of Korea.
Koyanagi A; ICREA, Pg. Lluis Companys 23, Barcelona, Spain; Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain.
Yang JW; Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
Jacob L; Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain; Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.
Yon DK; Department of Pediatrics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Lee SW; Department of Data Science, Sejong University College of Software Convergence, Seoul, Republic of Korea; Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Kim MS; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
Il Shin J; Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: shinji@yuhs.ac.
Smith L; Cambridge Centre for Health, Performance, and Wellbeing, Anglia Ruskin University, Cambridge, UK.

Pharmacol Res ; 176: 106052, 2022 02.

Article in En | MEDLINE | ID: mdl-34999224

Subject(s)

Melatonin/therapeutic use; Humans; Mental Disorders/drug therapy; Metabolic Diseases/drug therapy; Pain, Postoperative/drug therapy; Randomized Controlled Trials as Topic; Sleep Wake Disorders/drug therapy

Key words

Alprazolam (PubChem CID:2118); Clinical outcome; Clozapine (PubChem CID:135398737); Inositol (PubChem CID:892); Melatonin; Melatonin (PubChem CID:896); Midazolam (PubChem CID:4192); Olanzapine (PubChem CID:135398745); Oxazepam (PubChem CID:4616); Quetiapine (PubChem CID:5002); Randomized controlled trial; Risperidone (PubChem CID:5073); Umbrella review

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Melatonin Type of study: Clinical_trials / Diagnostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2022 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google